Loading…
Malignant peripheral nerve sheath tumor with analysis of various prognostic factors: A single-institutional experience
Context: Malignant peripheral nerve sheath tumor (MPNST) is a rare and aggressive soft-tissue sarcoma. Aims: The aim of this study was to analyze various prognostic factors and treatment outcome of patients with MPNST. Settings and Design: This was a retrospective study. Subjects and Methods: Ninety...
Saved in:
Published in: | Journal of cancer research and therapeutics 2021-01, Vol.17 (1), p.106-113 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c491n-2009d4a1a9db6d3012d9737f62104b84de79073658abf7b8e1c0e7e724ea91593 |
---|---|
cites | cdi_FETCH-LOGICAL-c491n-2009d4a1a9db6d3012d9737f62104b84de79073658abf7b8e1c0e7e724ea91593 |
container_end_page | 113 |
container_issue | 1 |
container_start_page | 106 |
container_title | Journal of cancer research and therapeutics |
container_volume | 17 |
creator | Sharma, Mohit Puj, Ketul Salunke, Abhijeet Pandya, Shashank Gandhi, Jahnavi Parikh, Ankita |
description | Context: Malignant peripheral nerve sheath tumor (MPNST) is a rare and aggressive soft-tissue sarcoma.
Aims: The aim of this study was to analyze various prognostic factors and treatment outcome of patients with MPNST.
Settings and Design: This was a retrospective study.
Subjects and Methods: Ninety-two patients, who presented with MPNST at a tertiary care cancer center from 2011 to 2018, were included in this study. The median follow-up of all living patients was 33 months. Neurofibromatosis 1 (NF1) was seen in 12 (13%) patients. Sixty (65.2%) patients received curative-intent treatment.
Statistical Analysis Used: Kaplan-Meier method was used for survival analysis. Log-rank test was used for univariate analysis, and multivariate analysis was done by Cox proportional hazard ratio method.
Results: The 5-year overall survival (OS) of all patients was 47.2% and the 5-year disease-free survival (DFS) of operated patients was 41.5%. On univariate analysis, association with NF1 (P = 0.009), grade (P = 0.017), and margin status (P = 0.002) had a significant effect on DFS, whereas association with NF1 (P = 0.025), metastatic disease on presentation (P < 0.0001), palliative intent of treatment (P < 0.0001), grade (P = 0.049), and margin status (P = 0.036) had a significant effect on OS. On multivariate analysis for patients who were treated with curative-intent treatment, grade (P = 0.015), and margin status (P = 0.028) had a significant effect on DFS, whereas association with NF1 (P = 0.00026) and location of tumor (P = 0.040) had a significant effect on OS.
Conclusions: The presence of distant metastasis, palliative intent of treatment, association with NF1, location of the tumor in the head and neck, high tumor grade, and positive margin status were the risk factors associated with poor survival for the patients with MPNST. Wide local excision with negative resection margin is the highly recommended treatment. |
doi_str_mv | 10.4103/jcrt.JCRT_854_19 |
format | article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2501851674</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A655948365</galeid><sourcerecordid>A655948365</sourcerecordid><originalsourceid>FETCH-LOGICAL-c491n-2009d4a1a9db6d3012d9737f62104b84de79073658abf7b8e1c0e7e724ea91593</originalsourceid><addsrcrecordid>eNp1kt1vFCEUxYnR2G313SdD4osvs8LAfODbduNnakxMfSYMc2eW7QyswOza_75MtjXVrOEBAr9z77nkIPSKkiWnhL3bah-XX9c_rmVdcEnFE7SgQtQZp6x-ihZEVCyjvM7P0HkIW0KKKs_r5-iMsSpnlJMF2n9Tg-mtshHvwJvdBrwasAW_Bxw2oOIGx2l0Hh9MOiqrhttgAnYd3itv3BTwzrveuhCNxp3S0fnwHq9wMLYfIDM2PcQpGpeUGH7PPcBqeIGedWoI8PJ-v0A_P364Xn_Orr5_-rJeXWWaC2qznBDRckWVaJuyZYTmbRqp6sqcEt7UvIVKkIqVRa2armpqoJpABVXOQQlaCHaB3h7rJpe_JghRjiZoGAZlIZmXeUFoXdCy4gl98w-6dZNPtmeK5alHIR5RvRpAGtu56JWei8pVWSSiTm4SlZ2gerDz7zoLnUnXf_HLE3xaLYxGnxSQo0B7F4KHTu68GZW_lZTIORpyjoZ8FI0keX0_39SM0P4RPGQhAZdH4OCGCD7cDNMBvEzsjXWH_xZOD6V8SBG7A4KFzM0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2532658594</pqid></control><display><type>article</type><title>Malignant peripheral nerve sheath tumor with analysis of various prognostic factors: A single-institutional experience</title><source>Publicly Available Content Database</source><creator>Sharma, Mohit ; Puj, Ketul ; Salunke, Abhijeet ; Pandya, Shashank ; Gandhi, Jahnavi ; Parikh, Ankita</creator><creatorcontrib>Sharma, Mohit ; Puj, Ketul ; Salunke, Abhijeet ; Pandya, Shashank ; Gandhi, Jahnavi ; Parikh, Ankita</creatorcontrib><description>Context: Malignant peripheral nerve sheath tumor (MPNST) is a rare and aggressive soft-tissue sarcoma.
Aims: The aim of this study was to analyze various prognostic factors and treatment outcome of patients with MPNST.
Settings and Design: This was a retrospective study.
Subjects and Methods: Ninety-two patients, who presented with MPNST at a tertiary care cancer center from 2011 to 2018, were included in this study. The median follow-up of all living patients was 33 months. Neurofibromatosis 1 (NF1) was seen in 12 (13%) patients. Sixty (65.2%) patients received curative-intent treatment.
Statistical Analysis Used: Kaplan-Meier method was used for survival analysis. Log-rank test was used for univariate analysis, and multivariate analysis was done by Cox proportional hazard ratio method.
Results: The 5-year overall survival (OS) of all patients was 47.2% and the 5-year disease-free survival (DFS) of operated patients was 41.5%. On univariate analysis, association with NF1 (P = 0.009), grade (P = 0.017), and margin status (P = 0.002) had a significant effect on DFS, whereas association with NF1 (P = 0.025), metastatic disease on presentation (P < 0.0001), palliative intent of treatment (P < 0.0001), grade (P = 0.049), and margin status (P = 0.036) had a significant effect on OS. On multivariate analysis for patients who were treated with curative-intent treatment, grade (P = 0.015), and margin status (P = 0.028) had a significant effect on DFS, whereas association with NF1 (P = 0.00026) and location of tumor (P = 0.040) had a significant effect on OS.
Conclusions: The presence of distant metastasis, palliative intent of treatment, association with NF1, location of the tumor in the head and neck, high tumor grade, and positive margin status were the risk factors associated with poor survival for the patients with MPNST. Wide local excision with negative resection margin is the highly recommended treatment.</description><identifier>ISSN: 0973-1482</identifier><identifier>EISSN: 1998-4138</identifier><identifier>DOI: 10.4103/jcrt.JCRT_854_19</identifier><identifier>PMID: 33723140</identifier><language>eng</language><publisher>India: Wolters Kluwer India Pvt. Ltd</publisher><subject>Adult ; Care and treatment ; Female ; Genetic disorders ; Humans ; Male ; Margins of Excision ; Medical prognosis ; Middle Aged ; Multivariate analysis ; Neoplasm Metastasis ; Nerve Sheath Neoplasms - genetics ; Nerve Sheath Neoplasms - pathology ; Nerve Sheath Neoplasms - surgery ; Nervous system tumors ; Neurological disorders ; Palliative Care - methods ; Patient outcomes ; Prognosis ; Retrospective Studies ; Risk Factors ; Sarcoma ; Survival analysis ; Survival Rate ; Treatment Outcome ; Tumors</subject><ispartof>Journal of cancer research and therapeutics, 2021-01, Vol.17 (1), p.106-113</ispartof><rights>COPYRIGHT 2021 Medknow Publications and Media Pvt. Ltd.</rights><rights>2021. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c491n-2009d4a1a9db6d3012d9737f62104b84de79073658abf7b8e1c0e7e724ea91593</citedby><cites>FETCH-LOGICAL-c491n-2009d4a1a9db6d3012d9737f62104b84de79073658abf7b8e1c0e7e724ea91593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2532658594?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25752,27923,27924,37011,37012,44589</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33723140$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sharma, Mohit</creatorcontrib><creatorcontrib>Puj, Ketul</creatorcontrib><creatorcontrib>Salunke, Abhijeet</creatorcontrib><creatorcontrib>Pandya, Shashank</creatorcontrib><creatorcontrib>Gandhi, Jahnavi</creatorcontrib><creatorcontrib>Parikh, Ankita</creatorcontrib><title>Malignant peripheral nerve sheath tumor with analysis of various prognostic factors: A single-institutional experience</title><title>Journal of cancer research and therapeutics</title><addtitle>J Cancer Res Ther</addtitle><description>Context: Malignant peripheral nerve sheath tumor (MPNST) is a rare and aggressive soft-tissue sarcoma.
Aims: The aim of this study was to analyze various prognostic factors and treatment outcome of patients with MPNST.
Settings and Design: This was a retrospective study.
Subjects and Methods: Ninety-two patients, who presented with MPNST at a tertiary care cancer center from 2011 to 2018, were included in this study. The median follow-up of all living patients was 33 months. Neurofibromatosis 1 (NF1) was seen in 12 (13%) patients. Sixty (65.2%) patients received curative-intent treatment.
Statistical Analysis Used: Kaplan-Meier method was used for survival analysis. Log-rank test was used for univariate analysis, and multivariate analysis was done by Cox proportional hazard ratio method.
Results: The 5-year overall survival (OS) of all patients was 47.2% and the 5-year disease-free survival (DFS) of operated patients was 41.5%. On univariate analysis, association with NF1 (P = 0.009), grade (P = 0.017), and margin status (P = 0.002) had a significant effect on DFS, whereas association with NF1 (P = 0.025), metastatic disease on presentation (P < 0.0001), palliative intent of treatment (P < 0.0001), grade (P = 0.049), and margin status (P = 0.036) had a significant effect on OS. On multivariate analysis for patients who were treated with curative-intent treatment, grade (P = 0.015), and margin status (P = 0.028) had a significant effect on DFS, whereas association with NF1 (P = 0.00026) and location of tumor (P = 0.040) had a significant effect on OS.
Conclusions: The presence of distant metastasis, palliative intent of treatment, association with NF1, location of the tumor in the head and neck, high tumor grade, and positive margin status were the risk factors associated with poor survival for the patients with MPNST. Wide local excision with negative resection margin is the highly recommended treatment.</description><subject>Adult</subject><subject>Care and treatment</subject><subject>Female</subject><subject>Genetic disorders</subject><subject>Humans</subject><subject>Male</subject><subject>Margins of Excision</subject><subject>Medical prognosis</subject><subject>Middle Aged</subject><subject>Multivariate analysis</subject><subject>Neoplasm Metastasis</subject><subject>Nerve Sheath Neoplasms - genetics</subject><subject>Nerve Sheath Neoplasms - pathology</subject><subject>Nerve Sheath Neoplasms - surgery</subject><subject>Nervous system tumors</subject><subject>Neurological disorders</subject><subject>Palliative Care - methods</subject><subject>Patient outcomes</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Sarcoma</subject><subject>Survival analysis</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><issn>0973-1482</issn><issn>1998-4138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp1kt1vFCEUxYnR2G313SdD4osvs8LAfODbduNnakxMfSYMc2eW7QyswOza_75MtjXVrOEBAr9z77nkIPSKkiWnhL3bah-XX9c_rmVdcEnFE7SgQtQZp6x-ihZEVCyjvM7P0HkIW0KKKs_r5-iMsSpnlJMF2n9Tg-mtshHvwJvdBrwasAW_Bxw2oOIGx2l0Hh9MOiqrhttgAnYd3itv3BTwzrveuhCNxp3S0fnwHq9wMLYfIDM2PcQpGpeUGH7PPcBqeIGedWoI8PJ-v0A_P364Xn_Orr5_-rJeXWWaC2qznBDRckWVaJuyZYTmbRqp6sqcEt7UvIVKkIqVRa2armpqoJpABVXOQQlaCHaB3h7rJpe_JghRjiZoGAZlIZmXeUFoXdCy4gl98w-6dZNPtmeK5alHIR5RvRpAGtu56JWei8pVWSSiTm4SlZ2gerDz7zoLnUnXf_HLE3xaLYxGnxSQo0B7F4KHTu68GZW_lZTIORpyjoZ8FI0keX0_39SM0P4RPGQhAZdH4OCGCD7cDNMBvEzsjXWH_xZOD6V8SBG7A4KFzM0</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Sharma, Mohit</creator><creator>Puj, Ketul</creator><creator>Salunke, Abhijeet</creator><creator>Pandya, Shashank</creator><creator>Gandhi, Jahnavi</creator><creator>Parikh, Ankita</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20210101</creationdate><title>Malignant peripheral nerve sheath tumor with analysis of various prognostic factors: A single-institutional experience</title><author>Sharma, Mohit ; Puj, Ketul ; Salunke, Abhijeet ; Pandya, Shashank ; Gandhi, Jahnavi ; Parikh, Ankita</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c491n-2009d4a1a9db6d3012d9737f62104b84de79073658abf7b8e1c0e7e724ea91593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Care and treatment</topic><topic>Female</topic><topic>Genetic disorders</topic><topic>Humans</topic><topic>Male</topic><topic>Margins of Excision</topic><topic>Medical prognosis</topic><topic>Middle Aged</topic><topic>Multivariate analysis</topic><topic>Neoplasm Metastasis</topic><topic>Nerve Sheath Neoplasms - genetics</topic><topic>Nerve Sheath Neoplasms - pathology</topic><topic>Nerve Sheath Neoplasms - surgery</topic><topic>Nervous system tumors</topic><topic>Neurological disorders</topic><topic>Palliative Care - methods</topic><topic>Patient outcomes</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Sarcoma</topic><topic>Survival analysis</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharma, Mohit</creatorcontrib><creatorcontrib>Puj, Ketul</creatorcontrib><creatorcontrib>Salunke, Abhijeet</creatorcontrib><creatorcontrib>Pandya, Shashank</creatorcontrib><creatorcontrib>Gandhi, Jahnavi</creatorcontrib><creatorcontrib>Parikh, Ankita</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cancer research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharma, Mohit</au><au>Puj, Ketul</au><au>Salunke, Abhijeet</au><au>Pandya, Shashank</au><au>Gandhi, Jahnavi</au><au>Parikh, Ankita</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Malignant peripheral nerve sheath tumor with analysis of various prognostic factors: A single-institutional experience</atitle><jtitle>Journal of cancer research and therapeutics</jtitle><addtitle>J Cancer Res Ther</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>17</volume><issue>1</issue><spage>106</spage><epage>113</epage><pages>106-113</pages><issn>0973-1482</issn><eissn>1998-4138</eissn><abstract>Context: Malignant peripheral nerve sheath tumor (MPNST) is a rare and aggressive soft-tissue sarcoma.
Aims: The aim of this study was to analyze various prognostic factors and treatment outcome of patients with MPNST.
Settings and Design: This was a retrospective study.
Subjects and Methods: Ninety-two patients, who presented with MPNST at a tertiary care cancer center from 2011 to 2018, were included in this study. The median follow-up of all living patients was 33 months. Neurofibromatosis 1 (NF1) was seen in 12 (13%) patients. Sixty (65.2%) patients received curative-intent treatment.
Statistical Analysis Used: Kaplan-Meier method was used for survival analysis. Log-rank test was used for univariate analysis, and multivariate analysis was done by Cox proportional hazard ratio method.
Results: The 5-year overall survival (OS) of all patients was 47.2% and the 5-year disease-free survival (DFS) of operated patients was 41.5%. On univariate analysis, association with NF1 (P = 0.009), grade (P = 0.017), and margin status (P = 0.002) had a significant effect on DFS, whereas association with NF1 (P = 0.025), metastatic disease on presentation (P < 0.0001), palliative intent of treatment (P < 0.0001), grade (P = 0.049), and margin status (P = 0.036) had a significant effect on OS. On multivariate analysis for patients who were treated with curative-intent treatment, grade (P = 0.015), and margin status (P = 0.028) had a significant effect on DFS, whereas association with NF1 (P = 0.00026) and location of tumor (P = 0.040) had a significant effect on OS.
Conclusions: The presence of distant metastasis, palliative intent of treatment, association with NF1, location of the tumor in the head and neck, high tumor grade, and positive margin status were the risk factors associated with poor survival for the patients with MPNST. Wide local excision with negative resection margin is the highly recommended treatment.</abstract><cop>India</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>33723140</pmid><doi>10.4103/jcrt.JCRT_854_19</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0973-1482 |
ispartof | Journal of cancer research and therapeutics, 2021-01, Vol.17 (1), p.106-113 |
issn | 0973-1482 1998-4138 |
language | eng |
recordid | cdi_proquest_miscellaneous_2501851674 |
source | Publicly Available Content Database |
subjects | Adult Care and treatment Female Genetic disorders Humans Male Margins of Excision Medical prognosis Middle Aged Multivariate analysis Neoplasm Metastasis Nerve Sheath Neoplasms - genetics Nerve Sheath Neoplasms - pathology Nerve Sheath Neoplasms - surgery Nervous system tumors Neurological disorders Palliative Care - methods Patient outcomes Prognosis Retrospective Studies Risk Factors Sarcoma Survival analysis Survival Rate Treatment Outcome Tumors |
title | Malignant peripheral nerve sheath tumor with analysis of various prognostic factors: A single-institutional experience |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T18%3A18%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Malignant%20peripheral%20nerve%20sheath%20tumor%20with%20analysis%20of%20various%20prognostic%20factors:%20A%20single-institutional%20experience&rft.jtitle=Journal%20of%20cancer%20research%20and%20therapeutics&rft.au=Sharma,%20Mohit&rft.date=2021-01-01&rft.volume=17&rft.issue=1&rft.spage=106&rft.epage=113&rft.pages=106-113&rft.issn=0973-1482&rft.eissn=1998-4138&rft_id=info:doi/10.4103/jcrt.JCRT_854_19&rft_dat=%3Cgale_proqu%3EA655948365%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c491n-2009d4a1a9db6d3012d9737f62104b84de79073658abf7b8e1c0e7e724ea91593%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2532658594&rft_id=info:pmid/33723140&rft_galeid=A655948365&rfr_iscdi=true |